Latticework
← Super investors

GSK

Gsk Plc-spon Adr

6 super-investor ownerscombined $3.26Blargest position 3.7%

6 super-investors hold GSK worth a combined $3.26B. The largest position: Hillman Capital Management at 3.7% of their portfolio. No cohort buying or selling was filed on the name this quarter. Cohort Conviction Score: 27 — ranked #482 of 724 scored stocks.

Share𝕏in

Why super-investors own GSK

Dodge & Cox dominates the cohort's $3.3B combined position, accounting for nearly all of it at 1.8% of their portfolio — the remaining five holders (Hillman Capital, Kahn Brothers, Tweedy Browne, Sarah Ketterer, and Richard Pzena) each carry negligible dollar weights. The 2026Q1 quarter saw zero activity across all six owners: no additions, no trims, no entries, no exits. The cohort count data shows a flat ownership trend, suggesting interest is neither building nor deteriorating. The dominant read here is passive conviction — Dodge & Cox's scale makes this effectively a one-firm thesis, with a handful of value-oriented satellites holding small legacy positions that haven't moved in at least two quarters.

AI-synthesized from 13F filings. Not investment advice.

Cohort owners over time

2025Q2 2026Q1

How many of the cohort members held this stock each quarter.

Now: 1
Peak: 1

Owners (6) · click any column to sort

Owners of GSK also hold

Long US equity 13F-HR filings only. CUSIP 37733W204. Not investment advice.